Drug-Induced Gingival Overgrowth

Overview

5 out of 5 (1 Reviews)

Credits

1.50

Post Assessment Questions

9

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes

Start This Activity
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Drug-induced gingival overgrowth (DIGO) is a condition characterized by an excessive enlargement of the gingival tissues due to the adverse events of certain systemic medications. The most frequently implicated drug classes include anticonvulsants such as phenytoin, immunosuppressants like cyclosporine, and calcium channel blockers, notably nifedipine and amlodipine. DIGO arises when these drugs alter the metabolism of gingival fibroblasts, leading to excessive extracellular matrix deposition and tissue proliferation. This condition typically presents as firm, fibrotic gingival tissue that may obscure the teeth, causing aesthetic and functional challenges, including difficulty in maintaining oral hygiene and an increased risk of periodontal infections. While the severity of DIGO varies based on individual susceptibility and drug dosage, contributing factors such as oral hygiene status and genetic predisposition significantly influence its progression.

This course provides participants with in-depth knowledge about DIGO's etiology, pathophysiology, and clinical manifestations, along with strategies for diagnosis and management. Participants gain insights into recognizing early signs of gingival overgrowth, assessing risk factors, and implementing preventive measures such as optimizing oral hygiene and evaluating alternative drug therapies where possible. The course emphasizes the importance of interprofessional collaboration involving dentists, pharmacists, and other healthcare professionals to create personalized treatment plans. This team-based approach facilitates timely interventions, promotes adherence to care recommendations, and enhances overall patient outcomes by reducing DIGO's functional and aesthetic impact while addressing the underlying systemic conditions requiring medication.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, nurse practitioners, and dentists.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Differentiate drug-induced gingival overgrowth from other causes of gingival enlargement, such as idiopathic gingival hyperplasia or inflammatory conditions.

  • Screen patients taking anticonvulsants, immunosuppressants, or calcium channel blockers for early signs of drug-induced gingival overgrowth to prevent progression.

  • Implement appropriate diagnostic protocols, including medical history reviews, drug interaction assessments, and oral examinations, to confirm drug-induced gingival overgrowth.

  • Communicate various interprofessional team strategies for improving care coordination and outcomes in patients with drug-induced gingival overgrowth.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

StatPearls, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the Commission of Continuing Provider Recognition at ADA.org/CERP.

Dentists: StatPearls, LLC designates this continuing education activity for 1.50 ADA credit(s). Dentists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Young J. on 11/22/2023

Unlimited Dentist CE

Stay up to date on the latest medical knowledge with 236 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 333 hours of CE.

6 Month Unlimited Dentist CE

Access to all the Unlimited Dentist CE activities.

$249 per half year per user

1 Year Unlimited Dentist CE

Access to all the Unlimited Dentist CE activities.

$349 per 1 year per user